24小时热门版块排行榜    

查看: 2300  |  回复: 9
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

xiangf

金虫 (小有名气)

[求助] Nexplanon的专利帮忙找找~~~~~~~~~~

Merck公司近日表示在美国上市68mg的Nexplanon (etonogestrel、依托孕烯) 皮下植入棒式避孕药。

这个避孕药的专利找不到,请高手们帮帮忙!!
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xiangf

金虫 (小有名气)

引用回帖:
: Originally posted by hnsqwxp at 2011-12-23 15:55:09:
楼主是要美国专利还是中国专利,是化合物专利还是制剂专利呢。

是这个商品对应的制剂专利,就是这个皮肤下植入剂的专利,其他的制剂不要,谢谢!
4楼2011-12-23 16:05:56
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 10 个回答

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

感谢参与,应助指数 +1
楼主是要美国专利还是中国专利,是化合物专利还是制剂专利呢。
2楼2011-12-23 15:55:09
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xiangf

金虫 (小有名气)

引用回帖:
: Originally posted by hnsqwxp at 2011-12-23 15:55:09:
楼主是要美国专利还是中国专利,是化合物专利还是制剂专利呢。

是这个产品的制剂专利,国内外的都可以,国内的为佳。
谢谢!
3楼2011-12-23 16:04:49
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

★ ★
豆哥(金币+2): 感谢参与交流 2011-12-24 09:24:38
Intrauterine system for retaining and releasing therapeutically effective dose of e.g. biologically active compound within uterus of human for treatment of e.g. menorraghia, has retention elements retaining frame within uterus of mammal
专利号: US2010280464-A1   ; WO2010128004-A1  
发明人:        DE GRAAFF W, VEENSTRA H, MARTINE T M T, MULDERS T M T
专利权人和代码:ORGANON NV(ORGA-C)
Derwent 主入藏号: 2010-N76468 [79]
被审查员引用的专利: 6       
摘要: NOVELTY - The system (200) has a deposit i.e. rod-shaped deposit, of a therapeutically effective dose of a biologically active compound. A frame defines an interior space for receipt of the deposit, where the frame has an open structure allowing access to a part of an outer surface of the deposit. Multiple retention elements retain the frame within a uterus of a female mammal. The frame interacts with the deposit to form a mechanical structure having a bending stiffness greater than the sum of that of the frame and deposit taken individually.

USE - Intrauterine system for retaining and releasing a therapeutically effective dose of a biologically active compound within uterus of female mammal i.e. human, for treatment of a medical condition e.g. dysfunctional uterine bleeding, menorraghia, dysmenorrhoea, endometriosis, uterine fibroids, climacteric complaints, osteoporosis and urogenital atrophy (all claimed). Uses include but are not limited to nomegestrol acetate (NOMAc), natural progesterone, levonogestrel, etonogestrel, dydrogesterone, medrogestone, medroxyprogesterone acetate, megestrol acetate, chlormadinone acetate and cyproterone acetate.

ADVANTAGE - The part of the outer surface of the deposit is directly exposed to an environment due to the open structure of the frame, so that the rate controlling effect on a steady state release of the compound to the uterus can be primarily determined by the structure of the deposit and the environment in which the structure is placed, thus enabling relatively easy prediction of release rates within the frame. The flexible frame and the deposit interact to form a composite mechanical structure, so that the system has greater mechanical strength such as bending stiffness, thus achieving an improved structure that ensures adequate strength while ensuring ease of insertion due to the small cross-section of the frame.

详细说明 - INDEPENDENT CLAIMS are also included for the following:

(1) a method for manufacturing an intrauterine system

(2) a method for treating a female mammal.

附图说明 - The drawing shows a perspective view of an intrauterine system prior to assembly.

Intrauterine system (200)

Stem (204)

Frame halves (205, 205')

Living hinges (207, 207')

Snap elements (209)

显示文献摘要
附图:

国际专利分类:        A61M-037/00; B23P-011/00; A61F-006/00; A61F-006/14; A61K-009/00
德温特分类代码:        A96 (Medical, dental, veterinary, cosmetic); B07 (General - tablets, dispensers, catheters); B01 (Steroids including systems with rings fused to basic steroid structure); P34 (Sterilising, syringes, electrotherapy); P56 (Machine tools)
德温特手工代码:        A11-B07; A12-V03D; B01-C03; B01-C04; B01-C05; B11-C03; B11-C04; B12-M10; B12-M12L; B14-D01B; B14-D01C; B14-F08; B14-H05; B14-N01A; B14-N07; B14-N14; B14-S18
专利详细信息:
专利号        公开日期        主 IPC        周        页数        语种
US2010280464-A1         04 Nov 2010        A61M-037/00        201079         Pages: 11         English
WO2010128004-A1         11 Nov 2010        A61F-006/14        201079                  English
申请详细信息:
US2010280464-A1         US770105         29 Apr 2010
WO2010128004-A1         WOEP055948         03 May 2010
优先权申请信息和日期:
EP159353         04 May 2009
指定国家 (地区)/区域:
WO2010128004-A1:
     国家 (地区): AE; AG; AL; AM; AO; AT; AU; AZ; BA; BB; BG; BH; BR; BW; BY; BZ; CA; CH; CL; CN; CO; CR; CU; CZ; DE; DK; DM; DO; DZ; EC; EE; EG; ES; FI; GB; GD; GE; GH; GM; GT; HN; HR; HU; ID; IL; IN; IS; JP; KE; KG; KM; KN; KP; KR; KZ; LA; LC; LK; LR; LS; LT; LU; LY; MA; MD; ME; MG; MK; MN; MW; MX; MY; MZ; NA; NG; NI; NO; NZ; OM; PE; PG; PH; PL; PT; RO; RS; RU; SC; SD; SE; SG; SK; SL; SM; ST; SV; SY; TH; TJ; TM; TN; TR; TT; TZ; UA; UG; US; UZ; VC; VN; ZA; ZM; ZW
化合物
DCR 号        特征描述        DCR 号        特征描述        DCR 号        特征描述
102210-1-0-0        (K M)        6478-1-0-0        (K M)        94705-1-0-0        (K M)
13759-2-0-0        (K M)        100334-1-0-0        (K M)        100338-1-0-0        (K M)
100358-1-0-0        (K M)        90738-1-0-0        (K M)        166768-1-0-0        (K M)
102310-2-0-0        (K M)
环系索引号:
10975
Derwent 化合物号:
化合物号        特征描述        化合物号        特征描述        化合物号        特征描述
R19407        (K M)        R00145        (K M)        RA2UMU        (K M)
R15326        (K M)        RA24UQ        (K M)        R00308        (K M)
R12004        (K M)        R01209        (K M)        R01250        (K M)
R04886        (K M)        R13690        (K M)
Derwent 注册号:
注册号        特征描述        注册号        特征描述        注册号        特征描述
0145        (S)        0308        (S)        1209        (S)
1250        (S)

这个是DII查到的信息,,wo专利里指定了CN的哦。

» 本帖已获得的红花(最新10朵)

5楼2011-12-23 16:07:28
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 没有任何消息-是不是就凉了 +7 图啦图啦 2026-08-24 8/400 2026-08-24 22:00 by maomao_da
[论文投稿] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 0XLacIJUOj8D 2026-08-24 3/150 2026-08-24 21:59 by BZKMTicpDhFj
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 0XLacIJUOj8D 2026-08-24 5/250 2026-08-24 21:51 by BZKMTicpDhFj
[基金申请] 人气不行了 +10 fansofjerry 2026-08-21 10/500 2026-08-24 21:03 by zhanghaozhu
[基金申请] 如果此刻你正在为国基感到焦虑,不妨来听听这首《基金之外》 +6 scalable 2026-08-24 6/300 2026-08-24 20:28 by 苦寒来香
[基金申请] 我面上完蛋了 +9 且听虎啸 2026-08-20 10/500 2026-08-24 20:08 by 苦寒来香
[基金申请] 能否退出参与的面上项目解除限项 +21 koalala 2026-08-24 24/1200 2026-08-24 19:25 by 家与远方
[基金申请] 建议基金发布提前给出明确的时间点 +13 kulium 2026-08-21 16/800 2026-08-24 16:27 by superceng
[基金申请] 朋友圈看到的 +7 wangzilk 2026-08-18 9/450 2026-08-24 10:50 by cmrandy
[基金申请] 放榜前的不淡定 20+4 snowwithsea 2026-08-19 17/850 2026-08-24 10:20 by echo8914667
[基金申请] 明天应该可查了!? +4 chengyan1220 2026-08-23 4/200 2026-08-24 08:47 by gloomy6159
[教师之家] 跳槽后在研项目怎么办? +5 简单化xn 2026-08-22 10/500 2026-08-23 12:38 by 简单化xn
[基金申请] 今天放榜吗? +15 布布和一二 2026-08-19 16/800 2026-08-23 09:55 by 张春生
[基金申请] 只有每年这种时候来逛逛小木虫 +24 yaoyewhu2008 2026-08-20 26/1300 2026-08-22 17:43 by kammury
[基金申请] 今天基金会出结果吗?20260819 +16 kkkl_v 2026-08-19 17/850 2026-08-22 16:12 by 阿布Abu
[基金申请] 看来今天不会放榜了? +8 chengyan1220 2026-08-21 11/550 2026-08-21 17:52 by dcqxinyang
[论文投稿] 投稿咨询 +5 wwm09 2026-08-17 7/350 2026-08-21 10:11 by 期刊论文帮手
[基金申请] 基金啊基金 +4 longfie172 2026-08-20 4/200 2026-08-21 08:58 by mark mao
[基金申请] 重要消息,中午系统在维护 +11 yuleib84 2026-08-18 12/600 2026-08-20 11:09 by xskun
[基金申请] 明天放榜? +5 Shxjjxjkx 2026-08-18 5/250 2026-08-18 18:14 by -大大大大大-
信息提示
请填处理意见